394 related articles for article (PubMed ID: 35859176)
1. ADAR1 averts fatal type I interferon induction by ZBP1.
Jiao H; Wachsmuth L; Wolf S; Lohmann J; Nagata M; Kaya GG; Oikonomou N; Kondylis V; Rogg M; Diebold M; Tröder SE; Zevnik B; Prinz M; Schell C; Young GR; Kassiotis G; Pasparakis M
Nature; 2022 Jul; 607(7920):776-783. PubMed ID: 35859176
[TBL] [Abstract][Full Text] [Related]
2. The RNA-editing enzyme ADAR1: a regulatory hub that tunes multiple dsRNA-sensing pathways.
Nakahama T; Kawahara Y
Int Immunol; 2023 Mar; 35(3):123-133. PubMed ID: 36469491
[TBL] [Abstract][Full Text] [Related]
3. ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation.
de Reuver R; Verdonck S; Dierick E; Nemegeer J; Hessmann E; Ahmad S; Jans M; Blancke G; Van Nieuwerburgh F; Botzki A; Vereecke L; van Loo G; Declercq W; Hur S; Vandenabeele P; Maelfait J
Nature; 2022 Jul; 607(7920):784-789. PubMed ID: 35859175
[TBL] [Abstract][Full Text] [Related]
4. Adenosine-to-inosine editing of endogenous Z-form RNA by the deaminase ADAR1 prevents spontaneous MAVS-dependent type I interferon responses.
Tang Q; Rigby RE; Young GR; Hvidt AK; Davis T; Tan TK; Bridgeman A; Townsend AR; Kassiotis G; Rehwinkel J
Immunity; 2021 Sep; 54(9):1961-1975.e5. PubMed ID: 34525337
[TBL] [Abstract][Full Text] [Related]
5. Z-nucleic-acid sensing triggers ZBP1-dependent necroptosis and inflammation.
Jiao H; Wachsmuth L; Kumari S; Schwarzer R; Lin J; Eren RO; Fisher A; Lane R; Young GR; Kassiotis G; Kaiser WJ; Pasparakis M
Nature; 2020 Apr; 580(7803):391-395. PubMed ID: 32296175
[TBL] [Abstract][Full Text] [Related]
6. ADAR1 mutation causes ZBP1-dependent immunopathology.
Hubbard NW; Ames JM; Maurano M; Chu LH; Somfleth KY; Gokhale NS; Werner M; Snyder JM; Lichauco K; Savan R; Stetson DB; Oberst A
Nature; 2022 Jul; 607(7920):769-775. PubMed ID: 35859177
[TBL] [Abstract][Full Text] [Related]
7. ADAR1 interaction with Z-RNA promotes editing of endogenous double-stranded RNA and prevents MDA5-dependent immune activation.
de Reuver R; Dierick E; Wiernicki B; Staes K; Seys L; De Meester E; Muyldermans T; Botzki A; Lambrecht BN; Van Nieuwerburgh F; Vandenabeele P; Maelfait J
Cell Rep; 2021 Aug; 36(6):109500. PubMed ID: 34380029
[TBL] [Abstract][Full Text] [Related]
8. ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis.
Zhang T; Yin C; Fedorov A; Qiao L; Bao H; Beknazarov N; Wang S; Gautam A; Williams RM; Crawford JC; Peri S; Studitsky V; Beg AA; Thomas PG; Walkley C; Xu Y; Poptsova M; Herbert A; Balachandran S
Nature; 2022 Jun; 606(7914):594-602. PubMed ID: 35614224
[TBL] [Abstract][Full Text] [Related]
9. Deciphering the Biological Significance of ADAR1-Z-RNA Interactions.
Nakahama T; Kawahara Y
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768866
[TBL] [Abstract][Full Text] [Related]
10. ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis.
Karki R; Sundaram B; Sharma BR; Lee S; Malireddi RKS; Nguyen LN; Christgen S; Zheng M; Wang Y; Samir P; Neale G; Vogel P; Kanneganti TD
Cell Rep; 2021 Oct; 37(3):109858. PubMed ID: 34686350
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the adenosine deaminase ADAR1 that prevent endogenous Z-RNA binding induce Aicardi-Goutières-syndrome-like encephalopathy.
Nakahama T; Kato Y; Shibuya T; Inoue M; Kim JI; Vongpipatana T; Todo H; Xing Y; Kawahara Y
Immunity; 2021 Sep; 54(9):1976-1988.e7. PubMed ID: 34525338
[TBL] [Abstract][Full Text] [Related]
12. Zα domain proteins mediate the immune response.
Zhong Y; Zhong X; Qiao L; Wu H; Liu C; Zhang T
Front Immunol; 2023; 14():1241694. PubMed ID: 37771585
[TBL] [Abstract][Full Text] [Related]
13. ZBP1 mediates interferon-induced necroptosis.
Yang D; Liang Y; Zhao S; Ding Y; Zhuang Q; Shi Q; Ai T; Wu SQ; Han J
Cell Mol Immunol; 2020 Apr; 17(4):356-368. PubMed ID: 31076724
[TBL] [Abstract][Full Text] [Related]
14. RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation.
Lin J; Kumari S; Kim C; Van TM; Wachsmuth L; Polykratis A; Pasparakis M
Nature; 2016 Dec; 540(7631):124-128. PubMed ID: 27819681
[TBL] [Abstract][Full Text] [Related]
15. Mendelian disease caused by variants affecting recognition of Z-DNA and Z-RNA by the Zα domain of the double-stranded RNA editing enzyme ADAR.
Herbert A
Eur J Hum Genet; 2020 Jan; 28(1):114-117. PubMed ID: 31320745
[TBL] [Abstract][Full Text] [Related]
16. Vaccinia virus E3 prevents sensing of Z-RNA to block ZBP1-dependent necroptosis.
Koehler H; Cotsmire S; Zhang T; Balachandran S; Upton JW; Langland J; Kalman D; Jacobs BL; Mocarski ES
Cell Host Microbe; 2021 Aug; 29(8):1266-1276.e5. PubMed ID: 34192517
[TBL] [Abstract][Full Text] [Related]
17. ADAR1 Zα domain P195A mutation activates the MDA5-dependent RNA-sensing signaling pathway in brain without decreasing overall RNA editing.
Guo X; Liu S; Sheng Y; Zenati M; Billiar T; Herbert A; Wang Q
Cell Rep; 2023 Jul; 42(7):112733. PubMed ID: 37421629
[TBL] [Abstract][Full Text] [Related]
18. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.
Mannion NM; Greenwood SM; Young R; Cox S; Brindle J; Read D; Nellåker C; Vesely C; Ponting CP; McLaughlin PJ; Jantsch MF; Dorin J; Adams IR; Scadden AD; Ohman M; Keegan LP; O'Connell MA
Cell Rep; 2014 Nov; 9(4):1482-94. PubMed ID: 25456137
[TBL] [Abstract][Full Text] [Related]
19. Influenza Virus Z-RNAs Induce ZBP1-Mediated Necroptosis.
Zhang T; Yin C; Boyd DF; Quarato G; Ingram JP; Shubina M; Ragan KB; Ishizuka T; Crawford JC; Tummers B; Rodriguez DA; Xue J; Peri S; Kaiser WJ; López CB; Xu Y; Upton JW; Thomas PG; Green DR; Balachandran S
Cell; 2020 Mar; 180(6):1115-1129.e13. PubMed ID: 32200799
[TBL] [Abstract][Full Text] [Related]
20. The phenotype of the most common human ADAR1p150 Zα mutation P193A in mice is partially penetrant.
Liang Z; Chalk AM; Taylor S; Goradia A; Heraud-Farlow JE; Walkley CR
EMBO Rep; 2023 May; 24(5):e55835. PubMed ID: 36975179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
